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Abstract
Background:  Depression and anxiety in patients with coronary heart disease (CHD) are
associated with a poorer prognosis. Therefore the screening for psychological distress is strongly
recommended in cardiac rehabilitation. The Hospital Anxiety and Depression Scale (HADS) is a
widely used screening tool that has demonstrated good sensitivity and specificity for mental
disorders.
Methods: We assessed mental distress in in-patient cardiac rehabilitation in Germany. The factor
structure of the German language version of the HADS was investigated in 1320 patients with
CHD. Exploratory factor analysis and confirmatory factor analysis were used to determine the
underlying factor structure of the instrument.
Results: Three-factor models were found to offer a superior fit to the data compared to two-
factor (anxiety and depression) models. The German language HADS performs similarly to the
English language version of the instrument in CHD patients. The German language HADS
fundamentally comprises a tri-dimensional underlying factor structure (labelled by Friedman et al.
as psychomotor agitation, psychic anxiety and depression).
Conclusion: Despite of clinical usefulness in screening for mental disturbances the construct
validity of the HADS is not clear. The resulting scores of the tri-dimensional model can be
interpreted as psychomotor agitation, psychic anxiety, and depression in individual patient data or
clinical investigations.
Background
Coronary heart disease (CHD) is of profound interest to
health and clinical psychology due to the high levels of
anxiety and depression observed in patients following the
occurrence of a coronary event [1-5]. CHD was the most
leading diagnosis for treatment in hospitals in Germany
for men (320,000 patients per year), and, after childbirth
and breast cancer, the third reason for in-patient treat-
ment for women (150,000 patients per year) [6]. Most in-
patient rehabilitation hospitalizations in Germany for
men (about 60,000 per year) were caused by CHD [7,8].
Recent research showed, that at least one in five patients
in cardiac rehabilitation suffer from a psychological disor-
der [9]. Accurate identification of significant anxiety and
depression as soon as possible following a cardiac event is
essential in order to facilitate delivery of an effective and
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comprehensive treatment package which takes into
account psychological as well as coronary disease symp-
toms [10]. This is particularly relevant since anxiety and
especially depression have been demonstrated to be pre-
dictors of mortality in this clinical group [11]. The availa-
bility of easy to administer, reliable and valid screening
tools would logically be a critical component of a clinical
protocol seeking to identify CHD patients with psycho-
logical disturbance. A suitable measure would readily
identify those patients for whom additional referral to a
clinical psychologist or to a liaison psychiatry service
would be more appropriate.
A candidate screening tool that has been widely and
increasingly used with CHD patients is the Hospital Anx-
iety and Depression Scale (HADS: [12]), an easily admin-
istered 14-item self-report measure comprising 7 anxiety
items and 7 depression items from which separate anxiety
and depression sub-scale scores are calculated [13]. The
HADS was designed to exclude symptoms that might arise
from the somatic aspects of illness such as insomnia, aner-
gia, and fatigue, therefore the instrument has been
designed for use within the clinical context of general
medicine. The HADS has been used for screening pur-
poses in a diverse and broad range of clinical groups [14-
24]. A number of investigations have suggested that the
HADS is a suitable instrument to accurately assess anxiety
and depression in CHD patients [10,17,24-27]. A funda-
mental assumption underpinning the clinical usefulness
of the HADS across a broad range of clinical groups,
including CHD, is that the instrument reliably assesses
anxiety and depression as two distinct and separable
dimensions [28].
On the other hand, recent psychometric evaluations of the
HADS in a range of clinical populations have suggested
that the proposed factor structure of the instrument may
indeed be compromised by the physiological aspects of
the disease or by changes in health status [23,29,30]. Con-
versely, there is accumulating evidence that the funda-
mental factor structure of the HADS comprises three
factors instead of two [24,26,31-33]. The finding that the
three-factor structure offers a superior fit to clinical data
than the two-factor (anxiety and depression) model for-
mulated as part of the original instrument development
by Zigmond and Snaith [12] has implications in terms of
the use, scoring and future development of this assess-
ment tool.
Dunbar et al. [32] found a three-factor structure of the
HADS in a non-clinical population (for an overview see
table 1) and interpreted their findings in relation to the
conceptually rich 'tripartite' model proposed by Clark and
Watson [34]. Extending these observations to a clinical
population, Friedman et al. [33] found a three-factor
structure to the HADS in a patient group being treated for
major depression, which incidentally, was similar to that
observed by Dunbar et al. [32]. Martin and Newell [35]
found that Friedman et al.'s [33] three-factor model
offered the best-fit to their data examining individuals
with significant facial disfigurement compared to compet-
ing two-factor models. Martin and Thompson [22]
observed a three-factor structure to the HADS in myocar-
dial infarction patients and, in a later study, Martin et al.
[26] extended further the findings of both Dunbar et al.
[32] and Friedman et al. [33] to myocardial infarction
patients finding additional support for the three-factor
structure suggested by these researchers to underlie the
HADS. A recent study [24] of the psychometric properties
of the HADS in Chinese acute coronary syndrome (ACS)
patients has established further support for the three-fac-
tor structure of the HADS furnishing evidence that the
three-dimensional structure of the instrument appears to
be consistent across diverse cultures. Caci et al. [31] sug-
gested a three-factor underlying structure to the HADS
that represents a modification to the three-factor model
identified by Friedman et al. [33] and replicated by Martin
et al. [26]. However, Caci et al.'s [31] model was based on
a student population and it should be remembered that
the presence of significant pathology or physiological
change states does impact on the underlying factor struc-
ture of this instrument [23,30,36]. The most consistent
contemporary observation in terms of the underlying fac-
tor structure of this instrument in cardiac patients is
strongly indicative that the HADS comprises three under-
lying dimensions. However, these cardiac studies have
used either clinical populations from the United Kingdom
[22,26] or from the Far East [24].
There has been little systematic investigation of the factor
structure of the translated HADS in German cardiac
patients, though interestingly a German language version
of the instrument has been developed in Germany using
cardiac patients within the context of the original
assumed two-dimensional (anxiety and depression) struc-
ture [37]. To date, the HADS has been found to comprise
a two-factor structure consistent with the anxiety and
depression sub-scales proposed by Zigmond and Snaith
[12] in cardiac [38] and non-clinical [39] populations in
Germany. However, these large studies did not investigate
the possibility that alternative factor models may provide
a better explanation of the data.
Identification of a coherent three-factor underlying struc-
ture of the HADS has a number of significant implications
in terms of the validity of the tool as a screening instru-
ment. Firstly, referral to mental health services could be
undermined based on a two-dimensional (anxiety and
depression) interpretation of HADS scores in cardiac
patients. Secondly, further replication of a three-factorHealth and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
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structure of the HADS in a German cardiac population
would be valuable in determining if the HADS should be
more effectively used as a screening instrument when
comprised of three sub-scales in this group. Thirdly, repli-
cation of a consistent three-factor structure in the Ger-
man-translated version of the HADS would provide
strong evidence that the three-dimensional structure is
implicit to the instrument and not a language-based arti-
fact. Finally, the widespread international use of the
HADS provides a compelling rationale to establish the
psychometric properties of the instrument not only in
broad diagnostic categories, but also across culturally-
diverse groups.
The purpose of the present study was to determine
whether the three-factor structure of the HADS identified
by Martin and colleagues [26] in myocardial infarction
patients in the UK and Martin et al. [24] in Chinese ACS
patients has the same psychometric properties as that of
the German-translated version of the HADS in a cohort of
German patients presenting with CHD. The present study
addresses two research questions:
1) Do exploratory factor analysis (EFA) and confirmatory
factor analysis (CFA) techniques concord to the proposed
bi-dimensional structure of the HADS in German CHD
patients?
2) Does a three-dimensional factor structure provide a
superior fit compared to competing bi-dimensional factor
structures?
Methods
Design
The study used a cross-sectional design with all measures
taken at one observation. The dependent variables were
sum scores obtained on the HADS (all items), and the
anxiety (HADS-A) and depression (HADS-D) sub-scales.
Exploratory factor analysis (EFA) and confirmatory factor
analysis (CFA) methods were used to address the research
questions using a pooled HADS data set from all patients.
Ethical approval for the study was given by the local ethi-
cal committee of the University Hospital of Freiburg. Writ-
ten informed consent was obtained from all participants
prior to the commencement of the study.
Procedure
The study was conducted in three German cardiac rehabil-
itation hospitals. The patients stay in these hospitals for
three to four weeks for a comprehensive cardiac rehabili-
tation program consisting of medical advice, exercise,
patient education, relaxation and psychosocial interven-
tions. All cardiac patients who agreed to take part in the
PROTeCD-study (Psychotherapeutic Resource-Orientated
Treatment for Cardiac Patients with Depression) were
Table 1: Characteristics of each factor model tested in earlier studies.
Model, author, year Number of 
factors
Clinical 
population
n Factor extrac-
tion method #
Allocation of items to scales
Zigmond & Snaith (1983) 2 Medical 100 No Factor analysis 
conducted
anxiety: 1, 3, 5, 7, 9, 11, 13
depression: 2, 4, 6, 8, 10, 12, 14
Moorey et al. (1991) 2 Cancer 568 PCA anxiety: 1, 3, 5, 9, 11, 13
depression: 2, 4, 6, 7, 8, 10, 12, 14
Dunbar et al. (2000) 3 Non-clinical 2,547 CFA autonomic anxiety: 3, 9, 13
negative affectivity: 1, 5, 7, 11
anhedonic depression: 2, 4, 6, 7,
Friedman et al. (2001)* 3 Depressed 2,669 PCA psychomotor agitation: 1, 7, 11
psychic anxiety: 3, 5, 9, 13
depression: 2, 4, 6, 8, 10, 12
Razavi et al. (1990) 1 Cancer 210 PCA All items included
Caci et al. (2003) 3 Non-clinical 195 CFA anxiety: 1, 3, 5, 9, 13
restlessness: 7, 11, 14
depression: 2, 4, 6, 8, 10, 12
*The three-factors are correlated in this model.
#PCA: Principal Components Analysis; CFA: Confirmatory Factor Analysis.Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
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screened for mental distress with the German version of
the HADS [37] at admission to hospital. Sociodemo-
graphic data were collected by self report and somatic data
were reported by physicians at study entry.
Statistical analysis
Exploratory factor analysis
Exploratory factor analysis was performed on the full 14-
item HADS using SPSS 12.0 statistical software. The crite-
rion chosen to determine that an extracted factor
accounted for a reasonably large proportion of the total
variance was based on an eigenvalue greater than 1. A
maximum likelihood factor extraction procedure was cho-
sen since this method of factor condensation is consistent
with our previous research [22] and is particularly useful
for extracting psychologically meaningful factors [40]. An
oblimin non-orthogonal factor rotation procedure was
chosen [40] due to the possibility that extracted factors are
likely to be correlated. Determination of a significant
item-factor loading was set at a coefficient level of 0.30 or
greater, this level based on a rationale of generating a
more complete psychological interpretation of the data
set, this being a level consistent with investigators who
have used EFA [22,30,36,41].
Confirmatory factor analysis
Confirmatory factor analysis was conducted using the
Analysis of Moment Structures (AMOS) version 4 [42] sta-
tistical software package. Eight models were tested. These
were Zigmond and Snaith's [12] original two-factor
model, Moorey et al.'s [43] two-factor model, Razavi et
al.'s [44] single-factor model, two versions of Clark and
Watson's [34] three-factor model as evaluated by Dunbar
and colleagues [32], Friedman et al.'s [33] three-factor
model and two versions of Caci et al.'s [31] three-factor
model. The characteristics and the allocation of the items
to the factors in each tested modelare shown in Table 1.
For all models, independence of error terms was specified.
Factors were allowed to be correlated where this was con-
sistent with the particular factor model being tested. Mul-
tiple goodness of fit tests [45] were used to evaluate the
eight models, these being the comparative fit index (CFI;
[46]), the Akaike information criterion (AIC; [47]), the
consistent Akaike information criterion (CAIC; [48]), the
normed fit index (NFI; [45]), the goodness of fit index
(GFI; [49]) and the root mean squared error of approxi-
mation (RMSEA). A CFI greater than 0.90 indicates a good
fit to the data [50]. A NFI and GFI greater than 0.90 indi-
cates a good fit to the data [51]. A RMSEA with values of
less than 0.08 indicates a good fit to the data [52], while
values greater than 0.10 suggest strongly that the model fit
is unsatisfactory. The AIC and CAIC are useful fit indices
for allowing comparison between models [32]. The Chi-
square goodness of fit test was also used to allow models
to be compared and to determine the acceptability of
model fit. A statistically significant χ 2 indicates a signifi-
cant proportion of variance remains unexplained by the
model [45].
Results
Participants
1320 patients (1035 male) enrolled in an in-patient car-
diac rehabilitation programme in three hospitals in Ger-
many provided complete HADS data sets for analysis.
Inclusion criteria for participation in the study was a con-
firmed diagnosis of CHD; for details see [53]. The patient
group comprised patients with a diagnosis of myocardial
infarction (N = 666), coronary artery bypass graft (N =
382), percutaneous transluminal coronary angioplasty (N
= 303) and unstable angina pectoris (N = 40). It is noted
that diagnostic N exceeds total cohort N because many
patients will have multiple CHD diagnoses. Patients were
required to have had a diagnosis of CHD and had a recent
cardiac event (MI, CABG, PTCA) in the past weeks. Female
patients (mean age = 62.88; SD = 12.14) were significantly
older, (t(401.14) = 4.14, p  < 0.001) than male patients
(mean age = 59.58; SD = 10.59).
Descriptive findings
The mean HADS-A sub-scale score was 6.14 (SD = 4.15,
range 0–20) and the mean HADS-D sub-scale score was
5.41 (SD = 4.00, range 0–20). Using Snaith and Zig-
mond's [28] cut-off criteria of HADS-A and HADS-D
scores of eight or over, 467 participants (35%) demon-
strated possible clinically relevant levels of anxiety and 373
participants (28%) possible  clinically relevant levels of
depression. Adopting Snaith and Zigmond's [28] higher
threshold for sensitivity of HADS-A and HADS-D scores of
eleven or over, 204 participants (15%) demonstrated
probable  clinically relevant levels of anxiety and 161
participants (12%) probable  clinically relevant levels of
depression.
Exploratory factor analysis
The Kaiser-Meyer-Olkin (KMO) measure of sampling ade-
quacy and the Bartlett Test of Sphericity (BTS) were con-
ducted on the data prior to factor extraction to ensure that
the characteristics of the data set were suitable for the EFA
to be conducted. KMO analysis yielded an index of 0.94,
and BTS (χ 2 = 7758.34, df = 91, p < 0.001) was highly sig-
nificant indicating the data satisfied the psychometric cri-
teria for the factor analysis to be performed based on data
distribution characteristics. Examination of individual
item skew and kurtosis characteristics confirmed the suit-
ability of the maximum likelihood factor extraction pro-
cedure [54]. Following extraction and oblimin rotation,
two factors with eigenvalues greater than 1 emerged from
analysis of the complete HADS and accumulatively
accounted for 53% of the total variance. Factor loadings of
individual HADS items in relation to the two-factor solu-Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
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tion are shown in Table 2. Factor scores were calculated
for each participant using regression and revealed the two
extracted factors to be highly statistically and positively
correlated, r = 0.82, p < 0.001, explaining 67% of the com-
mon variance between factors.
Confirmatory factor analysis
The factor models tested and accompanying fit indices are
shown in Table 3. χ 2 goodness of fit analyses for all mod-
els were highly statistically significant (p < 0.001) indicat-
ing that a proportion of the total variance was
unexplained by each model. Examination of the fit indi-
ces revealed that the best fit to the data was offered by
Friedman et al.'s [33] three-factor model (see figure 1).
This model provided consistently the best fit across all but
one model fit assessment criteria. It was also found that
both models of Dunbar et al.'s [32] three-factor model
evaluation of Clark and Watson's [34] 'tripartite' model
provided a 'best fit' to the data on a number of the fit indi-
ces tested (CFI, NFI and GFI) as did model 1 (CFI, NFI,
and GFI) and model 2 (CFI, AIC, NFI and GFI) of Caci et
al.'s [31] three-factor model. The two-factor models of
Table 2: Factor loadings of HADS items following maximum likelihood factor extraction with oblimin rotation
HAD Scale item Factor 1 Factor 2
Anxiety sub-scale
(1) I feel tense or wound up (AGI) 0.23 0.45
(3) I get a sort of frightened feeling as if something awful is about to happen (ANX) -0.02 0.75
(5) Worrying thoughts go through my mind (ANX) 0.09 0.69
(7) I can sit at ease and feel relaxed (AGI) 0.35 0.33
(9) I get a sort of frightened feeling like 'butterflies' in the stomach (ANX) -0.02 0.72
(11) I feel restless as if I have to be on the move (AGI) -0.01 0.43
(13) I get sudden feelings of panic (ANX) -0.02 0.75
Depression sub-scale
(2) I still enjoy the things I used to enjoy 0.95 -0.14
(4) I can laugh and see the funny side of things 0.87 -0.06
(6) I feel cheerful 0.72 0.01
(8) I feel as if I am slowed down 0.38 0.21
(10) I have lost interest in my appearance 0.40 0.08
(12) I look forward with enjoyment to things 0.65 0.09
(14) I can enjoy a good book or TV programme 0.42 0.19
Note: Bold indicates that item loading on a factor is 0.30 or above.
Factors in final model in figure 1; AGI: psychomotor agitation; ANX: psychic anxiety; DEP: remains the same
Table 3: Factor structure of the HADS determined by testing the fit of models derived from factor analysis. All χ 2 analyses were 
statistically significant at p < 0.01 (χ 2 degrees of freedom in parentheses).
Model χ 2 RMSEA CFI CAIC AIC NFI GFI
Zigmond and Snaith (1983) 481.47(76) 0.06 0.95 718.84 539.47 0.94 0.95
Moorey et al. (1991) 480.77(76) 0.06 0.95 718.15 538.77 0.94 0.95
Caci et al. (2003) model 1 391.55(74) 0.06 0.96 645.30 453.55 0.95 0.96
Caci et al. (2003) model 2 * 352.02(62) 0.06 0.96 589.40 410.02 0.95 0.96
Dunbar et al. (2000) model 1 396.56(73) 0.06 0.96 658.49 460.56 0.95 0.96
Dunbar et al. (2000) model 2 # 399.52(73) 0.06 0.96 661.45 463.52 0.95 0.96
Friedman et al. (2001) 361.41(74) 0.05 0.96 584.16 423.41 0.95 0.96
Razavi et al. (1990) 986.48(77) 0.09 0.88 1215.67 1042.48 0.87 0.88
Note: Bold indicates best model fit as a function of model fit index criterion.
* Three-factor model excludes item 10.
# Hierachical arrangement of factors.Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
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Standardised factor loadings and between-factor correlations of the Friedman et al. [33] model Figure 1
Standardised factor loadings and between-factor correlations of the Friedman et al. [33] model. Boxes repre-
sents HADS items labelled as shown as in table 2. Circles represents factors. One-way and two-way arrows indicate factor 
loadings and between-factor correlations, respectively.Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
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Zigmond and Snaith [12] and Moorey et al. [43] offered
poorer fits to the data compared to all three-factor models
evaluated, however against accepted model fit conven-
tion, these two-factor models still offered an acceptable fit
to the data. The single-factor model of Razavi et al. [44]
was observed to offer the poorest fit to the data across all
model fit estimates.
Discussion
The findings of the current study offer a further important
contribution to the evidence base regarding the underly-
ing factor structure of the widely used HADS. It is worthy
of note that high levels of HADS assessed anxiety and
depression were observed in the study. This finding is con-
sistent with investigators using this instrument in cardiac
populations in other parts of the world [22,24,26] and
verification of the need to screen for psychological distur-
bance in patients presenting with CHD.
The findings from the factor analyses conducted on the
HADS data are of pertinent methodological as well as clin-
ical interest. EFA of the HADS revealed two factors, the
loadings of individual items being consistent with the
anxiety and depression sub-scale domains. However, it
was also observed that the HADS-A item-7 'I can sit at ease
and feel relaxed' was jointly loading on both anxiety and
depression factors, this split-loading slightly in favour of
the depression factor. A recent EFA of the HADS con-
ducted with patients with significant facial disfigurement
[35] also revealed item-7 to be split-loaded between anxi-
ety and depression latent domains. Martin and Newell
[35] suggest that in circumstances of split-loading such as
those observed in the current study, a two-factor solution
may offer the most parsimonious solution in EFA, but
may not provide the best identification of factors in terms
of model fit. Martin and Newell's [35] rationale for this is
that EFA is not a model evaluation technique, therefore
identification of factors based on arbitrary cut-points such
as eigenvalues and scree plots is likely to produce a psy-
chometrically reductionist account of sophisticated
relationships between observed and latent variables. Mar-
tin and Newell [35] proposed that the lack of apriori
model specification in EFA provides a convincing psycho-
metrically plausible explanation of inconsistencies
between EFA and CFA in extracted factors and interpreta-
tion of data. Indeed, Martin and Newell [35] found a sim-
ilar finding to that of the current investigation, EFA
support for a two-factor model and CFA support for the
superiority of three-factor compared to two-factor mod-
els. Interestingly, Dagnan et al. [55] and Mykletun et al.
[56] identified three-factor initial solutions within the
HADS but chose to dismise the third-factor, without a
sound psychometric rationale. It is likely that an expecta-
tion of a presumed two-factor model makes it difficult to
reconcile an unexpected three-factor model emerging
from the data, therefore it is explainable why these
researchers might choose to dismiss a third factor.
The findings from the CFA revealed the best model fit to
be provided by Friedman et al.'s [33] three-factor mode
(see figure 1). The 'next best' fit to the data is offered by
Caci et al.'s [31] three-factor model 2. It was also observed
that the remaining three-factor models tested [31,32] not
only offered a good fit to the data but also provided a
superior fit to the data compared to the two-factor models
evaluated on a number of estimates of model fit. The two-
factor models of Zigmond and Snaith [12] and Moorey et
al. [43] did however offer an acceptable fit to the data. The
uni-dimensional model of Razavi et al. [44] was found to
offer a poor fit to the data, a finding consistent with previ-
ous research on the HADS across a variety of clinical
groups [19,24,26,30,35]. There remains little doubt from
the CFA analysis that the best fit to the data is offered by
three-factor models irrespective of the clinical population
from which the three-factor model was derived. The find-
ings from the CFA have furnished compelling support of
the HADS as a tri-dimensional instrument, consistent with
contemporary research with this instrument across diverse
clinical presentations [19,26,30,31,33,35].
Conclusion
In conclusion, the current study found the German lan-
guage version of the HADS to have an underlying three-
dimensional factor structure following CFA in CHD
patients, an observation consistent with UK [26] and Chi-
nese [24] CHD populations. The traditional interpreta-
tion of the HADS as a two-factor (anxiety and depression)
structure was also found to offer an acceptable fit to data,
though inferior to that of the three-factor models. It can
be concluded that the HADS may serve as useful screening
purpose by being scored as two sub-scales of anxiety and
depression. The clinical utilisation of the HADS continues
to be invaluable in screening for mental disorders. Our
results suggest that the assessment of the efficacy of inter-
ventions in evaluation studies by the HADS may be biased
by problems in construct validity. Two decades have
passed since the HADS was introduced to the clinical
screening battery. The findings of this study and those of
others, suggests that despite the clinical usefulness in
screening the individual results of the HADS could be
interpreted more precise in clinical routine. The differen-
tiation of the anxiety scale in "psychomotor agitation"
and "psychic anxiety" in the best fitting model may be
helpful in the interpretation of individual results of
patients. These results may improve our understanding of
the process of adaptation in patients with somatic illness.
A separate analysis of subscales in clinical trials may
reduce bias caused by somatic medical conditions of the
patients. Agitation might be more likely biased by the
medical status of the patients.Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
Page 8 of 9
(page number not for citation purposes)
Authors' contributions
JB designed the study, carried out the data collection and
clinical assessment. JB drafted part of the manuscript and
was involved in the interpretation of the findings. CRM
developed the statistical framework, carried out the statis-
tical analysis and drafted part of the manuscript. Both
authors have no competing financial or other interest in
relation to this manuscript.
Funding
The study was funded by the Federal Ministry of Educa-
tion and Research, Germany; Regional Pension Insurance
Institute, Baden-Wuerttemberg, Germany, LVA 02 804
and is part of the Rehabilitation Research Network South-
West (Germany).
Acknowledgements
We would like to thank the cooperation clinics (Klinikum für Akut- und 
Rehabilitationsmedizin Bad Krozingen, Germany, Prof. Bönner, Prof. Holu-
barsch; Theresienklinik Bad Krozingen, Germany, Prof. Jost) and all partic-
ipating patients. Our thanks goes also to all members of the PROTeCD 
working group (Prof. Dr. Dr. Bengel, Dipl. Psych. Nicole Englert, Prof. Dr. 
Dr. Martin Härter, Dipl. Psych. Juliane Paul) for their work in study design 
and patient recruitment. We thank also the reviewers of HQLO for helpful 
comments on an earlier version of this manuscript.
References
1. Ahern DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C,
Capone RJ, Schron E, Kornfeld D, Herd A, Richardson DW, Follick
MJ: Biobehavioral variables and mortality or cardiac arrest in
the cardiac arrhythmia pilot study. Am J Cardiol 1990, 66:59-62.
2. Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M: Post-inf-
arction depression and incomplete recovery 6 months after
acute myocardial infarction. Lancet 1994, 343:20-23.
3. Frasure-Smith N, Lesperance F, Talajic M: The impact of negative
emotions on prognosis following myocardial infarction: Is it
more than depression? Health Psychology 1995, 14:388-398.
4. Moser DK, Dragup K: Is anxiety early after myocardial infarc-
tion associated with subsequent ischemic and arrhytmic
events? Psychosom Med 1996, 58:395-401.
5. Thomas SA, Friedmann E, Wimbush F, Schron E: Psychological fac-
tors and survival in the cardiac arryhtmia supression trial
(CAST): a reexamination. Am J Crit Care 1997, 6:116-126.
6. Daten zum Gesundheitswesen 1997 [http://www.destatis.de/
themen/d/thm_gesundheit.php].
7. Franz IW: Herz-Kreislauf-Krankheiten. In Rehabilitationsmedizin:
Ambulant, teilstationär, stationär Edited by: Delbrück H, Haupt E.
München: Urban & Schwarzenberg; 1998:238-287. 
8. Rentenversicherungsträger VD: VDR Statistik Rehabilitation.
Würzburg: Universitätsdruckerei H. Stürtz; 2003. 
9. Härter M, Woll S, Reuter K, Wunsch A, Bengel J: Recognition and
psychiatric disorders in musculoskeletal and cardiovascular
rehabilitation patients. Arch Phys Med Rehabil 2004, 85:1192-1197.
10. Mayou RA, Gill D, Thompson DR, Hicks N, Volmink J, Neil A:
Depression and anxiety as predictors of outcome after myo-
cardial infarction. Psychosom Med 2000, 62:212-219.
11. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk
factor for mortality in patients with coronary heart disease:
a meta-analysis. Psychosom Med 2004, 66:802-813.
12. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression
Scale. Acta Psychiatrica Scandinavica 1983, 67:361-370.
13. Snaith RP: The Hospital Anxiety and Depression Scale. Health
and Quality of Life Outcomes 2003, 1(29):.
14. Barczak P, Kane N, Andrees S, Congdon AM, Clay JC, Betts T: Pat-
terns of psychiatric morbidity in a genito-urinary clinic. A
validation of the Hospital Anxiety Depression Scale (HAD).
Br J Psychiatry 1998, 152:698-700.
15. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the
Hospital Anxiety and Depression Scale. An updated litera-
ture review. J Psychosom Res 2002, 52:69-77.
16. Härter M, Reuter K, Gross-Hardt K, Bengel J: Screening for anxi-
ety, depressive and somatoform disorders in rehabilitation –
validity of HADS and GHQ-12 in patients with musculoskel-
etal disease. Disabil Rehabil 2001, 23:737-744.
17. Herrmann C: International experiences with the Hospital
Anxiety and Depression Scale: a review of validation data
and clinical results. J Psychosom Res 1997, 42:17-41.
18. Johnston M, Pollard B, Hennessey P: Construct validation of the
Hospital Anxiety and Depression Scale with clinical
populations. J Psychosom Res 2000, 48:579-584.
19. Jomeen J, Martin CR: Is the Hospital Anxiety and Depression
Scale (HADS) a reliable screening tool in early pregnancy?
Psychology and Health 2004, 19:787-800.
20. Martin CR, Bonner AB: A pilot investigation of the effect of try-
tophan manipulation on affective state in male chronic
alcoholics. Alcohol Alcohol 2000, 35:49-51.
21. Martin CR, Thompson DR: Prediction of quality of life in
patients with end-stage renal disease. British Journal of Health
Psychology 2000, 5:41-55.
22. Martin CR, Thompson DR: A psychometric evaluation of the
Hospital Anxiety and Depression Scale in coronary care
patients following acute myocardial infarction.  Psychology,
Health and Medicine 2000, 5:193-201.
23. Martin CR, Thompson DR, Chan DS: An examination of the psy-
chometric properties of the Hospital Anxiety and Depres-
sion Scale in Chinese patients with acute coronary
syndrome. Psychiatry Research 2004, 129:279-288.
24. Martin CR, Tweed AE, Metcalfe MS: A psychometric evaluation
of the Hospital Anxiety and Depression Scale in patients
diagnosed with end-stage renal disease. Br J Clin Psychol 2004,
43:51-64.
25. Lewin RJP, Thompson DR, Martin CR, Stuckey N, Devlen J, Michael-
son S, Maguire P: Validation of the Cardiovascular Limitations
and Symptoms Profile (CLASP) in chronic stable angina. Jour-
nal of Cardiopulmonary Rehabilitation 2002, 22:184-191.
26. Martin CR, Lewin RJP, Thompson DR: A confirmatory factor
analysis of the Hospital Anxiety and Depression Scale in cor-
onary care patients following acute myocardial infarction.
Psychiatry Research 2003, 120:85-94.
27. Mayou R, Springings D, Birkhead J, Price J: A randomized control-
led trial of a brief educational and psychological intervention
for patients presenting to a cardiac clinic with palpitation.
Psychological Medicine 2002, 32:699-706.
28. Snaith RP, Zigmond AS: The Hospital Anxiety and Depression
Scale Manual. NFER: Nelson, Windsor; 1994. 
29. Martin CR, Thompson DR: Utility of the Hospital Anxiety and
Depression Scale in patients with end-stage renal disease on
continuous ambulatory peritoneal dialysis. Psychology, Health
and Medicine 1999, 4:369-376.
30. McCue P, Martin CR, Buchanan T, Rodgers J, Scholey AB: An inves-
tigation into the psychometric properties of the Hospital
Anxiety and Depression Scale in individuals with Chronic
Fatigue Syndrome.  Psychology, Health and Medicine 2003,
8:425-440.
31. Caci LA, Bayle FJ, Mattel V, Dossios C, Robert P, Boyer P: How does
the Hospital Anxiety and Depression Scale measure anxiety
and depression in healthy subjects?  Psychiatry Report 2003,
118:89-99.
32. Dunbar M, Ford D, Hunt K, Der G: A confirmatory factor analy-
sis of the Hospital Anxiety and Depression Scale: comparing
empirically and theoretically derived structures.  Br J Clin
Psychol 2000, 39:79-94.
33. Friedmann S, Samuelian JC, Lancrenon S, Even C, Chiarelly P: Three-
dimesional structure of the Hospital Anxiety and Depression
Scale in a large French primary care population suffering
from major depression. Psychiatry Research 2001, 104:247-357.
34. Clark LA, Watson D: Tripartite model of anxiety and depres-
sion: psychometric evidence and taxonomic implications. J
Abnorm Psychol 1991, 100:316-336.
35. Martin CR, Newell RJ: Factor structure of the Hospital Anxiety
and Depression Scale in individuals with facial disfigurement.
Psychology, Health and Medicine 2004, 9:327-336.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2005, 3:15 http://www.hqlo.com/content/3/1/15
Page 9 of 9
(page number not for citation purposes)
36. Karimova G, Martin CR: A psychometric evaluation of the Hos-
pital Anxiety and Depression Scale during pregnancy. Psychol-
ogy, Health and Medicine 2003, 8:89-103.
37. Herrmann C, Buss U, Snaith RP: HADS-D: Hospital Anxiety and
Depression Scale – Deutsche Version. Testdokumentation
und Handanweisung. Bern: Huber; 1993. 
38. Herrmann C, Buss U: Vorstellung und Validierung einer deut-
schen Version der "Hospital Anxiety and Depression Scale"
(HAD-Skala). Diagnostica 1994, 40(2):143-154.
39. Hinz A, Schwarz R: Angst und Depression in der
Allgemeinbevölkerung.  Psychother Psychosom Med Psychol 2001,
51(5):193-200.
40. West R: Computing for Psychologists. Char: Harwood
Academic; 1991. 
41. Meadows K, Steen N, McColl E, Eccles M, Shiels C, Hewison J, Hutch-
inson A: The Diabetes Health Profile (DHP): a new instru-
ment for assessing the psychosocial profile of insulin
requiring patients: development and psychometric
evaluation. Quality of Life Research 1996, 5:242-254.
42. Arbuckle JL, Wothke W: AMOS 4.0 Users Guide. Chicago:
Smallwaters; 1999. 
43. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R,
Robertsond B, Bliss J: The factor structure and factor stability
of the Hospital Anxiety and Depression Scale in patients
with cancer. Br J Psychiatry 1991, 158:255-259.
44. Razavi D, Delvaux N, Farvacques C, Robaye E: Screening for
adjustment disorders and major depressive disorders in can-
cer in-patients. Br J Psychiatry 1990, 156:79-83.
45. Bentler PM, Bonett DG: Significance tests and goodness of fit in
the analysis of covariance structures.  Psychol Bull 1980,
88:588-606.
46. Bentler PM: Comparative fit indexes in structural models. Psy-
chol Bull 1988, 107:238-246.
47. Akaike H: Factor analysis and the AIC.  Psychometrika 1987,
52:317-332.
48. Bozdogan H: Model selection and Akaike's information crite-
rion (AIC): the general theory and its analytical extensions.
Psychometrika 1987, 52:345-370.
49. Joreskog KG, Sorbom D: LISREL 8 User's Reference Guide. Chi-
cago: Scientific Software International; 1993. 
50. Kline RB: Principles and Practice of Structural Equation
Modeling. New York: Guilford; 1998. 
51. Marsh HW, Balla JR, McDonald RP: Goodness-of-fit indices in
confirmatory factor analysis: the effect of sample size. Psychol
Bull 1988, 103:391-410.
52. Browne MW, Cudeck R: Alternative ways of assessing model
fit. Testing structural equation models. 1993:136-162.
53. Barth J, Paul J, Englert N, Härter M, Bengel J: Brief psychotherapy
for patients with coronary heart disease and co-morbid
depression. In Research in Rehabilitation – Results from a Rehabilitation
Network in Southwest Germany Edited by: Jäckel WH, Bengel J, Herdt J.
Stuttgart: Thieme  in press. 
54. Fabrigar IW, Wegener DT, Maccallum RC, Strahan EJ: Evaluating
the use of exploratory factor analysis in psychological
research. Psychological Methods 1999, 3:272-299.
55. Dagnan D, Chadwick P, Trower P: Psychometric properties of
the Hospital Anxiety and Depression Scale with a population
of members of a depression self-help group. Br J Med Psychol
2000, 73:129-137.
56. Mykletun A, Stordal E, Dahl AA: Hospital Anxiety and Depres-
sion (HAD) Scale: factor structure, item analyses and inter-
nal consistency in a large population.  Br J Psychiatry 2001,
179:540-544.